Similar articles for PMID: 19828955

Year	Number of Results
1991	2
1992	2
1993	2
1994	1
1995	2
1996	4
1997	5
1998	7
1999	5
2000	4
2001	3
2002	5
2003	5
2004	5
2005	10
2006	9
2007	8
2008	6
2009	9
2010	15
2011	14
2012	10
2013	15
2014	12
2015	10
2016	6
2017	4
2018	6
2019	4
2020	7
2021	6
2022	2
2023	1
2024	1

1

Quality of life improvements attributed to combination therapy with oral and topical mesalazine in mild-to-moderately active ulcerative colitis.

Connolly MP, Poole CD, Currie CJ, Marteau P, Nielsen SK. Connolly MP, et al. Digestion. 2009;80(4):241-6. doi: 10.1159/000235916. Epub 2009 Oct 15. Digestion. 2009. PMID: 19828955 Clinical Trial.

2

The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitis.

Irvine EJ, Yeh CH, Ramsey D, Stirling AL, Higgins PD. Irvine EJ, et al. Aliment Pharmacol Ther. 2008 Dec 1;28(11-12):1278-86. doi: 10.1111/j.1365-2036.2008.03854.x. Epub 2008 Sep 19. Aliment Pharmacol Ther. 2008. PMID: 18808446 Free article. Clinical Trial.

3

Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.

Sandborn WJ, Hanauer S, Lichtenstein GR, Safdi M, Edeline M, Scott Harris M. Sandborn WJ, et al. Aliment Pharmacol Ther. 2011 Oct;34(7):747-56. doi: 10.1111/j.1365-2036.2011.04800.x. Epub 2011 Aug 16. Aliment Pharmacol Ther. 2011. PMID: 21848857 Free article.

4

Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.

D'Haens G, Hommes D, Engels L, Baert F, van der Waaij L, Connor P, Ramage J, Dewit O, Palmen M, Stephenson D, Joseph R. D'Haens G, et al. Aliment Pharmacol Ther. 2006 Oct 1;24(7):1087-97. doi: 10.1111/j.1365-2036.2006.03082.x. Aliment Pharmacol Ther. 2006. PMID: 16984503 Free article. Clinical Trial.

5

A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis.

Safdi M, DeMicco M, Sninsky C, Banks P, Wruble L, Deren J, Koval G, Nichols T, Targan S, Fleishman C, Wiita B. Safdi M, et al. Am J Gastroenterol. 1997 Oct;92(10):1867-71. Am J Gastroenterol. 1997. PMID: 9382054 Clinical Trial.

6

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.

Marteau P, Probert CS, Lindgren S, Gassul M, Tan TG, Dignass A, Befrits R, Midhagen G, Rademaker J, Foldager M. Marteau P, et al. Gut. 2005 Jul;54(7):960-5. doi: 10.1136/gut.2004.060103. Gut. 2005. PMID: 15951542 Free PMC article. Clinical Trial.

7

Mesalazine (5-aminosalicylic acid) micropellets show similar efficacy and tolerability to mesalazine tablets in patients with ulcerative colitis--results from a randomized-controlled trial.

Raedler A, Behrens C, Bias P. Raedler A, et al. Aliment Pharmacol Ther. 2004 Dec;20(11-12):1353-63. doi: 10.1111/j.1365-2036.2004.02282.x. Aliment Pharmacol Ther. 2004. PMID: 15606398 Free article. Clinical Trial.

8

Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis.

Hartmann F, Stein J; BudMesa-Study Group. Hartmann F, et al. Aliment Pharmacol Ther. 2010 Aug;32(3):368-76. doi: 10.1111/j.1365-2036.2010.04354.x. Epub 2010 May 11. Aliment Pharmacol Ther. 2010. PMID: 20491741 Free article. Clinical Trial.

9

Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.

Miner PB Jr, Wedel MK, Xia S, Baker BF. Miner PB Jr, et al. Aliment Pharmacol Ther. 2006 May 15;23(10):1403-13. doi: 10.1111/j.1365-2036.2006.02837.x. Aliment Pharmacol Ther. 2006. PMID: 16669955 Free article. Clinical Trial.

10

Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.

Ardizzone S, Doldo P, Ranzi T, Sturniolo GC, Giglio LA, Annese V, D'Arienzo A, Gaia E, Gullini S, Riegler G, Valentini M, Massa P, Del Piano M, Rossini F, Guidetti CS, Pera A, Greinwald R, Bianchi Porro G. Ardizzone S, et al. Ital J Gastroenterol Hepatol. 1999 Nov;31(8):677-84. Ital J Gastroenterol Hepatol. 1999. PMID: 10730559 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

187 results

Results by year